Eliot A. Brinton, MD, obtained his medical degree from the University of Utah, completed a residency in internal medicine at Duke University, and received fellowship training in metabolism, endocrinology, and nutrition at the University of Washington in Seattle. He has served as an assistant professor of biochemical genetics and metabolism at the Rockefeller University in New York, as an associate professor of medicine and director of the Clinical Lipid Center at Wake Forest University, as chief of Metabolism, Endocrinology and Nutrition at the Carl T. Hayden Veterans Affairs Medical Center in Phoenix, Arizona, as associate professor of clinical medicine at the University of Arizona College of Medicine, as adjunct professor of cellular and molecular biology at Arizona State University, and as co-director of the Phoenix Citywide Endocrinology and Metabolism Fellowship Program. Dr. Brinton currently directs the Metabolism Section of the Cardiovascular Genetics Department and serves as associate professor at the University of Utah School of Medicine in Salt Lake City. He also is the president of the Utah Atherosclerosis Society and a founding board member both of the National Lipid Association and of the American Board of Clinical Lipidology in the United States. He is Past- President of the Pacific Lipid Association, the western regional chapter of the National Lipid Association. Dr. Brinton is widely published in the field of lipoprotein metabolism, having published original research articles in the New England Journal of Medicine, JAMA, and Circulation. He is assistant editor of the Journal of Obesity, has served as section editor of Current Opinion in Atherosclerosis and is on the editorial boards of the Journal of Clinical Endocrinology and Metabolism, the Journal of Managed Care Pharmacy and Future Lipidology. He has held numerous leadership and advisory positions in scientific and governmental organizations and in the pharmaceutical industry.